Oregon Department of Corrections
Approved Formulary
Search by name
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Hazardous Drugs
In-Cell HD
Earned In-Cell
Formulary Duration Restrictions
Therapeutic Substitutions
Webpage Links
Add Formweb to your mobile device
Android
iOS
Home
QuickStart
Admin
February P&T meeting minutes have been posted.
Oregon Department of Corrections
Approved Formulary
Search by name
Additional search options
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Hazardous Drugs
In-Cell HD
Earned In-Cell
Formulary Duration Restrictions
Therapeutic Substitutions
Webpage Links
Search results for:
benztropine
benztropine
Cell Status
Approved (oral); NFISA (injection)
Brand names:
Benztropine Mesylate, Cogentin
Form
Strength
SOLUTION, INJECTABLE
1 mg/mL
TABLET, ORAL
0.5 mg; 1 mg; 2 mg
Last updated:
Jan. 24, 2018
FDA Drug Safety:
Benztropine Mesylate Injection by Fresenius Kabi USA: Recall - Potential Presence Of Glass Particles
FDA Drug Safety:
Benztropine Mesylate Injection (Nexus Pharmaceuticals): Recall - Visible Particulate Matter
UpToDate
Micromedex
Pharmacist's Letter
FDA DailyMed Package Insert
WebMD Pill Identifier